Introduction Neurocognitive disorders, including Mild Cognitive Impairment (MCI), Alzheimer’s disease, and other forms of dementia, are becoming an increasingly pressing health concern in the UK and Europe. These conditions affect memory, cognition, and daily functionality, often leaving families searching for innovative treatment options beyond conventional medicine. While pharmaceuticals such as cholinesterase inhibitors and memantine provide […]
Introduction Alzheimer’s disease is one of the most devastating neurological disorders of our time. Affecting millions of individuals worldwide, it gradually erodes memory, cognitive ability, and independence. Families across the UK and Europe are faced with the emotional and financial strain of caring for loved ones as the disease progresses. Conventional medications provide only limited […]